Manipulating the expression of CFTR/pendrin in epithelial cells, developing effective channel inhibitors and activators to regulate anti-oxidative function and efficacy are strategies that have potential clinical significance in treating elderly patients with COPD. This evidence concerns the gene CFTR and chronic obstructive pulmonary disease.